Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 9840
TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349629BDBM349629(sodium 1-(2-(4-(2-(4-fluoro-2,6- dimethylbenzoyl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349628BDBM349628((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (4-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349627BDBM349627((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349626BDBM349626((4-f1uoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349625BDBM349625((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349625BDBM349625((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349624BDBM349624((S)-(4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349624BDBM349624((S)-(4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349623BDBM349623((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349623BDBM349623((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349622BDBM349622((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(3- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349622BDBM349622((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(3- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349621BDBM349621((3-(4-(aminomethyl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349630BDBM349630(US10208011, Compound RAD- | US10981887, Compound R...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349630BDBM349630(US10208011, Compound RAD- | US10981887, Compound R...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349629BDBM349629(sodium 1-(2-(4-(2-(4-fluoro-2,6- dimethylbenzoyl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349613BDBM349613((3-(4-(2-(azepan-1-yl)ethoxy)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349612BDBM349612((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349612BDBM349612((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349611BDBM349611((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349610BDBM349610((3-(4-(2-aminoethyl)phenoxy)-6- hydroxybenzo[b]thi...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349610BDBM349610((3-(4-(2-aminoethyl)phenoxy)-6- hydroxybenzo[b]thi...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349609BDBM349609((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349608BDBM349608((3-(4-(azepan-1-yl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349608BDBM349608((3-(4-(azepan-1-yl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349607BDBM349607((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349607BDBM349607((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349606BDBM349606((3-(4-(2-(ethylamino)ethyl)phenoxy)-6- hydroxybenz...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349606BDBM349606((3-(4-(2-(ethylamino)ethyl)phenoxy)-6- hydroxybenz...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349621BDBM349621((3-(4-(aminomethyl)phenoxy)-6- hydroxybenzo[b]thio...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349620BDBM349620((3-(4-((dimethylamino)methyl)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349620BDBM349620((3-(4-((dimethylamino)methyl)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349619BDBM349619((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4- ((m...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349619BDBM349619((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4- ((m...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349618BDBM349618((3-(4-(2-(diethylamino)ethyl)phenoxy)-6- hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349618BDBM349618((3-(4-(2-(diethylamino)ethyl)phenoxy)-6- hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349617BDBM349617((3-(4-(2-(sec- butylamino)ethyl)phenoxy)-6- hydrox...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349617BDBM349617((3-(4-(2-(sec- butylamino)ethyl)phenoxy)-6- hydrox...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349616BDBM349616((3-(4-(2- (cyclohexylamino)ethyl)phenoxy)-6- hydro...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349616BDBM349616((3-(4-(2- (cyclohexylamino)ethyl)phenoxy)-6- hydro...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349615BDBM349615((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349615BDBM349615((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349614BDBM349614((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349614BDBM349614((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349613BDBM349613((3-(4-(2-(azepan-1-yl)ethoxy)phenoxy)- 6-hydroxybe...)
Affinity DataIC50: 1.00E+3nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349628BDBM349628((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (4-(fluorom...)
Affinity DataIC50: 5.00E+4nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349627BDBM349627((4-fluoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 5.00E+4nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349611BDBM349611((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(2- ...)
Affinity DataIC50: 5.00E+4nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349626BDBM349626((4-f1uoro-2,6-dimethylphenyl)(3-(4-(2- (3-(fluorom...)
Affinity DataIC50: 5.00E+4nMAssay Description:All reagents used in this assay was supplied in the Human ERα Reporter Assay by Indigo Biosciences #IB00401. In an effort to screen selective es...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
G1 Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 349609BDBM349609((4-fluoro-2,6-dimethylphenyl)(6- hydroxy-3-(4-(pip...)
Affinity DataIC50: 5.00E+4nMAssay Description:A screening strategy was implemented utilizing an In-Cell Western assay to measure their ability to degrade the estrogen receptor in vitro. MCF7 cell...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent